titlesubmit dateissue date
Now showing items 1-15 of 15
A Two-Dimensional Human Minilung System (Model) for Respiratory Syncytial Virus Infections
Chimeric Pneumoviridae fusion proteins as immunogens to induce cross-neutralizing antibody responses
Eight Year Prospective Study of Adenoviruses Infections in Hospitalized Children. Comparison with Other Respiratory Viruses
Epidemiology and clinical characteristics of respiratory syncytial virus infections among children and adults in Mexico
Exogenous, TAP-independent lysosomal presentation of a respiratory syncytial virus CTL epitope.
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
Human respiratory syncytial virus infects and induces activation markers in mouse B lymphocytes.
Induction of DNA double-strand breaks and cellular senescence by human respiratory syncytial virus
Influence of respiratory syncytial virus strain differences on pathogenesis and immunity
ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state.
Respiratory Syncytial Virus Coinfections With Rhinovirus and Human Bocavirus in Hospitalized Children
Respiratory syncytial virus inhibits ciliagenesis in differentiated normal human bronchial epithelial cells: effectiveness of N-acetylcysteine
Roflumilast inhibits respiratory syncytial virus infection in human differentiated bronchial epithelial cells
Unusual viral ligand with alternative interactions is presented by HLA-Cw4 in human respiratory syncytial virus-infected cells.